Exhaled nitric oxide (NO) in patients with respiratory tract diseases;Stȩżenie tlenku azotu (NO) w powietrzu wydychanym u chorych ze schorzeniami układu oddechowego

Polski Merkuriusz Lekarski

Volumn 16, Issue 92, 2004, Pages 115-118

  Ziȩtkowski, Ziemowit ^a   Bodzenta łukaszyk, Anna ^a  

^a Klinika Reumatologii i Chorob Wewnetrznych   (Poland)

Author keywords

Asthma; Exhaled nitric oxide; Pollinosis

Indexed keywords

NITRIC OXIDE;

ALLERGIC DISEASE; ARTICLE; ASTHMA; CHEMOLUMINESCENCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EXPIRED AIR; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; NON INVASIVE MEASUREMENT; POLLEN ALLERGY; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE; SMOKING; ADOLESCENT; ADULT; AGED; CASE CONTROL STUDY; EXHALATION; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGED; ASTHMA; CASE-CONTROL STUDIES; EXHALATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES; SMOKING;

EID: 3042666874     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ali-Ali M.K. i wsp.: Exhaled nitric oxide; relationship to clinicophysiological markers of asthma severity. Respir. Med., 1998, 92, 908-913.
2. Alving K.: Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J., 1993, 6, 1368-1370.
3. Clini E. i wsp.: Endogenous nitric oxide in patients with stable COPD: correlates with severity of disease. Thorax, 1998, 53, 881-883.
4. Geller D.A. i wsp.: Cytokines, endotoxin and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci., 1993, 90, 522-528.
5. Gratziou C. i wsp.: Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis. Eur. Respir. J., 1999, 14, 897-901.
6. Gustafsson L.E. i wsp.: Endogenous nitric oxide is present in the exhaled air of rabbits, guinea-pigs and humans. Biochem. Biophys. Res. Commun., 1991, 181, 852-857.
7. Hovarth I., Barnes P.J.: Exhaled monoxides in asymptomatic atopic subjects. Clin. Exp. Allergy, 1999, 29, 1276-1280.
8. Jatakanon A. i wsp.: Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998, 53, 91-95.
9. Kanazawa H. i wsp.: Role of endogenous nitric oxide in exercise-induced airway narrowing in patients with bronchial asthma. J. Allergy Clin. Immunol., 2000, 106, 1081-1085.
10. Kharitonov S.A. i wsp.: Allergen-induced late asthmatic response are associated with elevation of exhaled nitric oxide. Am. J. Respit. Crit. Care Med., 1995, 151, 1894-1899.
11. Kharitonov S.A. i wsp.: Dose-dependent onset and duration of action of 100/400 mcg budesonide on exhaled nitric oxide and related changes in other potential markers of airway inflammation in asthma. Eur. Respir. J., 2000, 16 (Suppl. 31), 340S.
12. Kharitonov S.A. i wsp.: Reproducibility, reliability and diurnal variation of standardized exhaled NO measurements with NIOX in healthy and asthmatic children and adults made in routine clinical practice. Eur. Respir. J., 2001, 18, 4S.
13. Kroncke K.D. i wsp.: Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol. Chem., 1995, 376, 327-330.
14. Ludviksdottir D. i wsp.: Exhaled nitric oxide and its relationship to airway responsiveness and atopy in asthma. BHR-Study Group. Respir. Med., 1999, 93, 552-556.
15. Maziak W. i wsp.: Exhaled nitric oxide in chronic obstructive pulmonary disease. Am. J. Respit. Crit. Care Med., 1998, 157, 998-1002.
16. Moncada S. i wsp.: Nitric oxide: Physiology, patophysiology ad pharmacology. Pharmacol. Rev., 1991, 48, 109-112.
17. Nussler A.K. i wsp.: Inflammation, immunoregulation and inducible nitric oxide synthase. J. Leukoc. Biol., 1993, 54, 171-174.
18. Papi A. i wsp.: Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am. J. Respit. Crit. Care Med., 2000, 162, 1773-1777.
19. Rutgers S.R. i wsp.: Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Thorax, 1999, 54, 576-580.
20. Sanders S.P.: Nitric oxide in asthma. Am. J. Respir. Cell Mol. Biol., 1999, 21, 147.
21. Schilling J. i wsp.: Reduced endogenous nitric oxide in exhaled air of smokers and hypertensives. Eur. Respir. J., 1994, 7, 1501-1504.
22. Silkoff P.E. i wsp.: Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest, 2001, 119, 1322-1328.
23. Van den Toorn L.M. i wsp.: Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med., 2000, 162, 953.